Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 3Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Melanoma 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Oxaliplatin 21Fluorouracil 20Leucovorin 19Capecitabine 18Irinotecan 13Radiotherapy 8Bevacizumab 7Cetuximab 6Folfox protocol 4cediranib 2Radiation 2Psychiatric Rehabilitation 2Octreotide 2Cisplatin 2Chemoradiotherapy 2tipifarnib 1pertuzumab 1olaparib 1mercaptoundecahydrododecaborate 1eniluracil 1durvalumab 1brivanib 1alpha-Tocopherol 1Watchful Waiting 1Vitamin E 1Trastuzumab 1Tegafur 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Rectal Neoplasms × Immunoenzyme Techniques × Clear all
NCT00897754 2017-05-19

Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab

Eastern Cooperative Oncology Group

Completed
200 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡